156 related articles for article (PubMed ID: 15334700)
21. Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT).
Wöll E; Greil R; Eisterer W; Bechter O; Fridrik MA; Grünberger B; Zabernigg A; Mayrbäurl B; Russ G; Dlaska M; Obrist P; Thaler J
Anticancer Res; 2011 Dec; 31(12):4439-43. PubMed ID: 22199312
[TBL] [Abstract][Full Text] [Related]
22. DNA polymerase η protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy.
Teng KY; Qiu MZ; Li ZH; Luo HY; Zeng ZL; Luo RZ; Zhang HZ; Wang ZQ; Li YH; Xu RH
J Transl Med; 2010 Nov; 8():126. PubMed ID: 21110884
[TBL] [Abstract][Full Text] [Related]
23. [Mechanisms of oxaliplatin-induced apoptosis of human multiple myeloma cell RPMI8226].
Liu BL; Liu X; Zhou NC; Qi MY; Xu B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):99-104. PubMed ID: 23484700
[TBL] [Abstract][Full Text] [Related]
24. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
De Vita F; Orditura M; Matano E; Bianco R; Carlomagno C; Infusino S; Damiano V; Simeone E; Diadema MR; Lieto E; Castellano P; Pepe S; De Placido S; Galizia G; Di Martino N; Ciardiello F; Catalano G; Bianco AR
Br J Cancer; 2005 May; 92(9):1644-9. PubMed ID: 15856038
[TBL] [Abstract][Full Text] [Related]
25. [Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer].
Zhao Q; Li Y; Tan BB; Tian Y; Jiao ZK; Zhao XF; Zhang ZD; Wang D; Yang PG
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):773-7. PubMed ID: 24378101
[TBL] [Abstract][Full Text] [Related]
26. [Impact of S100P expression on clinical outcomes of gastric cancer patients with adjuvant chemotherapy of oxaliplatin and its mechanisms].
Zhao XM; Bai ZG; Ma XM; Zhang ZT; Shi XY
Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):1004-8. PubMed ID: 21054985
[TBL] [Abstract][Full Text] [Related]
27. [The treatment of retinal apoptosis by Caspase 3 inhibitor Ac-DEVD-CHO in experimental myopia].
Liu SZ; Mao JF; Wen D; Tan XP; Fu CY
Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):428-33. PubMed ID: 15938808
[TBL] [Abstract][Full Text] [Related]
28. [Clinical results of advanced gastric cancer patients treated with oxaliplatin-containing regimen].
Zhang WM; Xu GH; Ju AP; Zheng YT; Jiang Q
Ai Zheng; 2003 Dec; 22(12):1346-8. PubMed ID: 14693066
[TBL] [Abstract][Full Text] [Related]
29. Caspase-3 inhibitor transiently delays inherited retinal degeneration in C3H mice carrying the rd gene.
Yoshizawa K; Kiuchi K; Nambu H; Yang J; Senzaki H; Kiyozuka Y; Shikata N; Tsubura A
Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):214-9. PubMed ID: 11935279
[TBL] [Abstract][Full Text] [Related]
30. Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms.
Coudray AM; Louvet C; Kornprobst M; Raymond E; André T; Tournigand C; Faivre S; De Gramont A; Larsen AK; Gespach C
Int J Oncol; 2005 Aug; 27(2):553-61. PubMed ID: 16010439
[TBL] [Abstract][Full Text] [Related]
31. [Diallyl trisulfide induces apoptosis of human gastric cancer cell line MGC803 through caspase-3 pathway].
Xiao XL; Peng J; Su Q; Xiang SL; Tang GH; Huang YS; Zhou XT
Ai Zheng; 2006 Oct; 25(10):1247-51. PubMed ID: 17059769
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
Nukatsuka M; Nakagawa F; Takechi T
Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
[TBL] [Abstract][Full Text] [Related]
33. Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.
Seo HY; Kim DS; Choi YS; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Cancer Chemother Pharmacol; 2009 Feb; 63(3):433-9. PubMed ID: 18398608
[TBL] [Abstract][Full Text] [Related]
34. Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer.
Sym SJ; Ryu MH; Kang HJ; Lee SS; Chang HM; Lee JL; Kim TW; Yook JH; Oh ST; Kim BS; Kang YK
Cancer Chemother Pharmacol; 2010 Jul; 66(2):373-80. PubMed ID: 19936751
[TBL] [Abstract][Full Text] [Related]
35. N-acetyl cysteine inhibits human signet ring cell gastric cancer cell line (SJ-89) cell growth by inducing apoptosis and DNA synthesis arrest.
Li J; Tu HJ; Li J; Dai G; Dai YC; Wu Q; Shi QZ; Cao Q; Li ZJ
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):769-74. PubMed ID: 17700262
[TBL] [Abstract][Full Text] [Related]
36. [Oxaliplatin in combination with calcium folinate and fluorouracil as neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Fang Y; Wang YJ; Li F; Li J
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):510-2. PubMed ID: 17143797
[TBL] [Abstract][Full Text] [Related]
37. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
38. [Introduction of oxaliplatin for treating unresectable advanced or recurrent gastric cancer in clinical practice].
Sato A
Gan To Kagaku Ryoho; 2015 Apr; 42(4):443-6. PubMed ID: 25963690
[TBL] [Abstract][Full Text] [Related]
39. P38 Signal Transduction Pathway Has More Cofactors on Apoptosis of SGC-7901 Gastric Cancer Cells Induced by Combination of Rutin and Oxaliplatin.
Li Q; Ren L; Zhang Y; Gu Z; Tan Q; Zhang T; Qin M; Chen S
Biomed Res Int; 2019; 2019():6407210. PubMed ID: 31781632
[TBL] [Abstract][Full Text] [Related]
40. Synergistic enhancement of the antitumor activity of 5-fluorouracil by bornyl acetate in SGC-7901 human gastric cancer cells and the determination of the underlying mechanism of action.
Li J; Wang SX
J BUON; 2016; 21(1):108-17. PubMed ID: 27061538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
